menu
    • menu

    Company profile for Psilera

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Many pharmaceutical drugs originate from nature due to safety profiles and intrinsic biological activity that has been optimized through trial and time. A shift towards natural products is evident from significant interest and clinical data identifying cannabis and psychedelics as emerging therapeutics. Psilera will leverage its research strengths led by executives from the pharmaceutical and cannabis industries to develop a ...
    Many pharmaceutical drugs originate from nature due to safety profiles and intrinsic biological activity that has been optimized through trial and time. A shift towards natural products is evident from significant interest and clinical data identifying cannabis and psychedelics as emerging therapeutics. Psilera will leverage its research strengths led by executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of psychedelic analogues. Lead compounds are formulated and screened with neurological targets to evaluate clinical potential with pipeline candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PsileraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3201 W. Hillsborough Ave., 151868, Tampa, Florida 33614
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.psilera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/psilera/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Psilera Secures NIH Grant For AUD Research
    Psilera Secures NIH Grant For AUD Research

    03 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psilera-inc-secures-national-institutes-of-health-grant-for-aud-research-302573406.html

    PR NEWSWIRE
    03 Oct 2025
    Share Share
    Scott Rairigh Appointed by Psilera for Corporate Development
    Scott Rairigh Appointed by Psilera for Corporate Development

    04 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/healthcare-industry-veteran-scott-rairigh-joins-psilera-to-lead-corporate-development-302546005.html

    PR NEWSWIRE
    04 Sep 2025
    Share Share
    Psilera Partners with Hesperos to advance PSIL-006 for Dementia
    Psilera Partners with Hesperos to advance PSIL-006 for Dementia

    09 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psilera-collaborates-with-drug-development-leader-hesperos-to-advance-preclinical-modeling-of-psil-006-for-frontotemporal-dementia-302475744.html

    PR NEWSWIRE
    09 Jun 2025
    Share Share
    Psilera & Atai Sign Licensing Agreement For DMT Patent Portfolio
    Psilera & Atai Sign Licensing Agreement For DMT Patent Portfolio

    20 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psilera-inc--atai-life-sciences-announce-licensing-agreement-for-dmt-patent-portfolio-302380822.html

    PR NEWSWIRE
    20 Feb 2025
    Share Share
    Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors
    Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors

    26 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psilera-welcomes-biopharma-executive-dr-magali-haas-to-its-board-of-directors-302099546.html

    PR NEWSWIRE
    26 Mar 2024
    Share Share
    Psilera Announces Lead Indication for PSIL-006
    Psilera Announces Lead Indication for PSIL-006

    23 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psilera-announces-lead-indication-for-psil-006-behavioral-variant-frontotemporal-dementia-bvftd-302041782.html

    PR NEWSWIRE
    23 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search